PAR DRUGS AND CHEM LTDPP

PAR DRUGS AND CHEM LTD

102.45INRR
+4.87+4.99%
Pada penutup 7 Mac, 09:46 GMT
INR
Tiada dagangan
Lihat pada carta super

Asas PAR

Penyata kewangan PAR DRUGS AND CHEM LTD, termasuk hasil, perbelanjaan dan keuntungan

Jumlah hasil PAR untuk suku lepas adalah 213.81 M INR, dan 38.31% nya lebih rendah daripada suku sebelum ini. Pendapatan bersih untuk Q3 24 adalah 5.78 M INR.

Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪90.00 M‬‬
‪‪180.00 M‬‬
‪‪270.00 M‬‬
‪‪360.00 M‬‬
Jumlah hasil
Untung Kasar
Pendapatan kendalian
Pendapatan pracukai
Pendapatan bersih
Mata wang: INR
Q1 '21
Jun 2021
Q2 '21
Sep 2021
Q3 '21
Dis 2021
Q4 '21
Mac 2022
Q1 '22
Jun 2022
Q2 '22
Sep 2022
Q3 '22
Dis 2022
Q4 '22
Mac 2023
Q1 '23
Jun 2023
Q2 '23
Sep 2023
Q3 '23
Dis 2023
Q4 '23
Mac 2024
Q1 '24
Jun 2024
Q2 '24
Sep 2024
Q3 '24
Dis 2024
TTM
Jumlah hasilPertumbuhan tahun ke tahun
‪‪244.92 M‬‬
+10.92%
‪‪229.35 M‬‬
−2.43%
‪‪258.87 M‬‬
+4.31%
‪‪239.99 M‬‬
+4.65%
‪‪228.19 M‬‬
−6.83%
‪‪226.06 M‬‬
−1.43%
‪‪346.57 M‬‬
+33.88%
‪‪213.81 M‬‬
−10.91%
‪‪1.01 B‬‬
‪‪−112.41 M‬‬
‪‪−116.25 M‬‬
‪‪−110.24 M‬‬
‪‪−101.52 M‬‬
‪‪−99.26 M‬‬
‪‪−96.52 M‬‬
‪‪−143.26 M‬‬
‪‪−110.44 M‬‬
‪‪−449.48 M‬‬
Untung KasarPertumbuhan tahun ke tahun
‪‪132.51 M‬‬
+25.42%
‪‪113.10 M‬‬
+2.69%
‪‪148.63 M‬‬
+19.42%
‪‪138.47 M‬‬
+30.74%
‪‪128.93 M‬‬
−2.70%
‪‪129.54 M‬‬
+14.54%
‪‪203.31 M‬‬
+36.78%
‪‪103.37 M‬‬
−25.35%
‪‪565.15 M‬‬
‪‪−87.16 M‬‬
‪‪−80.09 M‬‬
‪‪−83.49 M‬‬
‪‪−94.84 M‬‬
‪‪−76.91 M‬‬
‪‪−96.23 M‬‬
‪‪−98.31 M‬‬
‪‪−98.23 M‬‬
‪‪−369.67 M‬‬
Pendapatan kendalianPertumbuhan tahun ke tahun
‪‪45.35 M‬‬
+24.08%
‪‪33.01 M‬‬
+11.56%
‪‪65.15 M‬‬
+30.50%
‪‪43.64 M‬‬
+75.38%
‪‪52.02 M‬‬
+14.71%
‪‪33.31 M‬‬
+0.91%
‪‪105.00 M‬‬
+61.18%
‪‪5.15 M‬‬
−88.20%
‪‪195.48 M‬‬
‪‪45.00 K‬‬
‪‪−35.00 K‬‬
‪‪224.00 K‬‬
‪‪2.09 M‬‬
‪‪−931.00 K‬‬
‪‪536.00 K‬‬
‪‪9.87 M‬‬
‪‪2.58 M‬‬
‪‪12.05 M‬‬
Pendapatan pracukaiPertumbuhan tahun ke tahun
‪‪45.39 M‬‬
+25.11%
‪‪32.97 M‬‬
+7.56%
‪‪65.37 M‬‬
+31.32%
‪‪45.73 M‬‬
+83.19%
‪‪51.09 M‬‬
+12.55%
‪‪33.85 M‬‬
+2.66%
‪‪114.87 M‬‬
+75.72%
‪‪7.72 M‬‬
−83.11%
‪‪207.53 M‬‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪‪−10.93 M‬‬
‪‪−8.30 M‬‬
‪‪−16.45 M‬‬
‪‪−11.51 M‬‬
‪‪−13.89 M‬‬
‪‪−8.52 M‬‬
‪‪−28.91 M‬‬
‪‪−1.94 M‬‬
‪‪−53.27 M‬‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪‪34.47 M‬‬
‪‪24.68 M‬‬
‪‪48.92 M‬‬
‪‪34.22 M‬‬
‪‪37.19 M‬‬
‪‪25.33 M‬‬
‪‪85.96 M‬‬
‪‪5.78 M‬‬
‪‪154.26 M‬‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
Pendapatan bersihPertumbuhan tahun ke tahun
‪‪34.47 M‬‬
+42.29%
‪‪24.68 M‬‬
+7.56%
‪‪48.92 M‬‬
+31.32%
‪‪34.22 M‬‬
+83.20%
‪‪37.19 M‬‬
+7.91%
‪‪25.33 M‬‬
+2.66%
‪‪85.96 M‬‬
+75.72%
‪‪5.78 M‬‬
−83.11%
‪‪154.26 M‬‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪‪34.47 M‬‬
‪‪24.68 M‬‬
‪‪48.92 M‬‬
‪‪34.22 M‬‬
‪‪37.19 M‬‬
‪‪25.33 M‬‬
‪‪85.96 M‬‬
‪‪5.78 M‬‬
‪‪154.26 M‬‬
Perolehan asas sesaham (EPS Asas)Pertumbuhan tahun ke tahun
‪2.80‬
+42.29%
‪2.01‬
+7.56%
‪3.98‬
+31.32%
‪2.78‬
+83.20%
‪3.02‬
+7.91%
‪2.06‬
+2.66%
‪6.99‬
+75.72%
‪0.47‬
−83.11%
‪12.54‬
‪2.80‬
+42.29%
‪2.01‬
+7.56%
‪3.98‬
+31.32%
‪2.78‬
+83.20%
‪3.02‬
+7.91%
‪2.06‬
+2.66%
‪6.99‬
+75.72%
‪0.47‬
−83.11%
‪12.54‬
‪‪12.30 M‬‬
‪‪12.30 M‬‬
‪‪12.30 M‬‬
‪‪12.30 M‬‬
‪‪12.30 M‬‬
‪‪12.30 M‬‬
‪‪12.30 M‬‬
‪‪12.30 M‬‬
‪‪12.30 M‬‬
‪‪12.30 M‬‬
‪‪12.30 M‬‬
‪‪12.30 M‬‬
‪‪12.30 M‬‬
‪‪12.30 M‬‬
‪‪12.30 M‬‬
‪‪12.30 M‬‬
EBITDAPertumbuhan tahun ke tahun
‪‪53.83 M‬‬
+19.04%
‪‪41.32 M‬‬
+12.01%
‪‪73.63 M‬‬
+24.69%
‪‪52.29 M‬‬
+61.85%
‪‪60.94 M‬‬
+13.21%
‪‪42.35 M‬‬
+2.49%
‪‪114.08 M‬‬
+54.95%
‪‪14.29 M‬‬
−72.67%
‪‪231.66 M‬‬
EBITPertumbuhan tahun ke tahun
‪‪45.35 M‬‬
+24.08%
‪‪33.01 M‬‬
+11.56%
‪‪65.15 M‬‬
+30.50%
‪‪43.64 M‬‬
+75.38%
‪‪52.02 M‬‬
+14.71%
‪‪33.31 M‬‬
+0.91%
‪‪105.00 M‬‬
+61.18%
‪‪5.15 M‬‬
−88.20%
‪‪195.48 M‬‬
‪‪−199.57 M‬‬
‪‪−196.34 M‬‬
‪‪−193.73 M‬‬
‪‪−196.35 M‬‬
‪‪−176.17 M‬‬
‪‪−192.74 M‬‬
‪‪−241.57 M‬‬
‪‪−208.66 M‬‬
‪‪−819.15 M‬‬